Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-7c2ld Total loading time: 0.974 Render date: 2021-12-08T11:02:58.651Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Laboratory-Confirmed Influenza B Infection in Immunized Long-Term Care Facility Residents Receiving Oseltamivir Prophylaxis in Ontario

Published online by Cambridge University Press:  02 January 2015

Anne-Luise Winter*
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Adriana Peci
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
AliReza Eshaghi
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Michelle Baird
Affiliation:
City of Hamilton Public Health Services, Hamilton, Ontario, Canada
Nader Memari
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Erik Kristjanson
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Elizabeth Balogun
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Rachel R. Higgins
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
Aimin Li
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada
David J. Farrell
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada
Jonathan B. Gubbay
Affiliation:
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada The Hospital for Sick Children, Toronto, Ontario, Canada
*
Ontario Agency for Health Protection and Promotion, 480 University Avenue, 3rd Floor, Toronto, Ontario M5G 1V2, Canada (anne-luise.winter@oahpp.ca)

Abstract

We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them had resistance identified.

Type
Concise Communication
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Lindley, RI. Influenza in aged care facilities. Rev Clin Gerontol 2011;21:9197.CrossRefGoogle Scholar
2.Public Health Ontario Laboratories Labstracts. http://www.oahpp.ca/resources/labstracts.html. Accessed April 1, 2013.Google Scholar
3.Hall, TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:9598.Google Scholar
4.Tamura, K, Peterson, D, Peterson, N, Stecher, G, Nei, M, Kumar, S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28:27312739.CrossRefGoogle ScholarPubMed
5.Thorlund, K, Awad, T, Boivin, G, Thabane, L. Systematic review of influenza resistance to neuraminidase inhibitors. BMC Infect Dis 2011;11:134.CrossRefGoogle ScholarPubMed
6.Leung, WHA. An outbreak of influenza A pandemic (H1N1) 2009 in a residential home for the disabled in Hong Kong and detection of the first local case of oseltamivir-resistant infection. Abstract, 14th International Congress on Infectious Diseases.Google Scholar
7.Monto, AS, Hornebuckle, K, Ohmit, SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 2001;154:155160.CrossRefGoogle ScholarPubMed
8.Okomo-Adhiambo, M, Sleeman, K, Ballenger, K, et al. Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective. Viruses 2010;2:22692289.CrossRefGoogle ScholarPubMed
1
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Laboratory-Confirmed Influenza B Infection in Immunized Long-Term Care Facility Residents Receiving Oseltamivir Prophylaxis in Ontario
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Laboratory-Confirmed Influenza B Infection in Immunized Long-Term Care Facility Residents Receiving Oseltamivir Prophylaxis in Ontario
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Laboratory-Confirmed Influenza B Infection in Immunized Long-Term Care Facility Residents Receiving Oseltamivir Prophylaxis in Ontario
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *